Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anixa Biosciences Inc ANIX

Healthcare Biotechnology
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well... see more

Recent & Breaking News (NDAQ:ANIX)

Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

PR Newswire September 8, 2021

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

PR Newswire September 7, 2021

Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy

PR Newswire August 30, 2021

Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant

PR Newswire August 25, 2021

Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative

PR Newswire August 23, 2021

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

PR Newswire August 18, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

PR Newswire May 26, 2021

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

PR Newswire May 20, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

PR Newswire May 7, 2021

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

PR Newswire April 19, 2021

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

PR Newswire April 5, 2021

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

PR Newswire March 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

PR Newswire March 22, 2021

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

PR Newswire March 22, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

PR Newswire March 12, 2021

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

PR Newswire March 8, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

PR Newswire March 4, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

PR Newswire February 25, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

PR Newswire February 16, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

PR Newswire January 13, 2021